BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 08, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Helsinn, Specialised Therapeutics Australia sales and marketing update

Helsinn Healthcare granted Specialised Therapeutics exclusive rights to commercialize Aloxi palonosetron in Australia and New Zealand. Further deal terms were...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >